Investor Presentaiton
Novo Nordisk Annual Report 2023
PURPOSE AND SUSTAINABILITY
Driving change for
a sustainable future
Introducing Novo Nordisk Strategic Aspirations
Risks
Management
Consolidated statements
Additional information
11
ФФ
In a world facing urgent societal
and environmental challenges,
Novo Nordisk is playing a proactive
role in the fight against health
inequity and climate change. Guided
by our purpose of driving change
to defeat serious chronic diseases
and a steadfast commitment to
social, environmental and financial
responsibility, we are raising the
bar to stay at the forefront of
progressive global businesses.
Human health is under threat from a perfect storm of health
inequity, climate change and biodiversity loss. As a leading
healthcare company committed to serving patients across the
globe, we have an important role to play in addressing these
challenges. Our commitment to social responsibility and
minimising our environmental impact are key to achieving our
purpose and sustainability goals - and essential for our
long-term success.
That is why we are striving to improve access to affordable care
for vulnerable patients across the globe. More than three
quarters of people with diabetes, for example, live in low- and
middle-income countries, and that proportion is likely to grow
as global prevalence rises from an estimated 537 million adults
today to a predicted 643 million by 2030. Although we are now
serving more people with diabetes than ever before, expanding
our reach by more than four million patients to a total of 40.5
million last year, we recognise the need to do more.
Our key contribution to society remains our therapeutic
innovation. However, we realise it will take more than medicine
to defeat serious chronic diseases. This need is particularly
acute in obesity, where medical intervention with treatments
like WegovyⓇ must be supplemented with prevention measures
to head off a global pandemic that threatens to overwhelm
healthcare systems. To this end, we have strengthened our
focus on public-private partnerships and established a
dedicated Transformational Prevention Unit tasked with
delivering scalable commercial solutions that can help predict
and pre-empt obesity.
We are also stepping up efforts to reduce our environmental
impact by focusing on our supply chain emissions. Having already
switched our production sites to sourcing 100% renewable power
in 2020, we are now focused on supporting our 60,000-plus
suppliers through a similar transition, with the aim of reaching
net zero emissions across our full value chain by 2045.
To ensure that sustainability is integrated into Novo Nordisk's core
business, we have a series of governance measures in place that
supplement the incorporation of environmental, social and
financial responsibility in our Articles of Association. These include
our Sustainability Advisory Council, established in 2022, which
provides external input on our goals from experts in academia,
public policy and patient advocacy, and an executive remuneration
package directly linked to our progress on sustainability targets.
STRATEGIC ASPIRATIONS 2025
1. Progress towards zero
environmental impact
2. Being respected for adding
value to society
3. Being recognised as
a sustainable employer
For an overview of our purpose and
sustainability initiatives, frameworks
and performance, see the tables on
pages 102-104.View entire presentation